Skip to main content
. 2017 Jul 27;117(5):710–716. doi: 10.1038/bjc.2017.223

Table 2. Details on test methodologies applied by participant laboratories.

Laboratory Primary test strategy NGS platform
Method
Lab 1 Sequencing (NGS) Illumina HiSeq2500 Hybridisation selection (TruSight Cancer Panel (Illumina))
Lab 2 Sequencing (NGS) Illumina NextSeq500 Hybridisation selection (TruSight Cancer Panel (Illumina))
Lab 3 Sequencing (NGS) Illumina MiSeq Long amplicon (Lab Developed Test)
Lab 4 Sequencing (NGS) Illumina MiSeq Long amplicon (Lab Developed Test)
Lab 5 Sequencing (NGS) Illumina MiSeq Short amplicon (BRCA1/BRCA2/TP53 kit (Fluidigm))
Lab 6 Sequencing (NGS) Illumina MiSeq Hybridisation selection (Lab Developed Test (Haloplex))
Lab 7 Sequencing (NGS) Illumina MiSeq Short amplicon (BRCA MASTR Dx (Multiplicom))
Lab 8 Sequencing (NGS) Illumina MiSeq Short amplicon (BRCA MASTR Dx (Multiplicom))
Lab 9 Sequencing (NGS) Illumina MiSeq Hybridisation selection (Lab Developed Test)
Lab 10 Sequencing (NGS) Illumina MiSeq Hybridisation selection (SureSelect (Illumina))
Lab 11 Sequencing (NGS) Life Technologies 1 IonPGM Short amplicon (Ion AmpliSeq BRCA1 and BRCA2 Panel (Life Technologies))
Lab 12 Sequencing (NGS) Life Technologies IonPGM Short amplicon (Ion AmpliSeq BRCA1 and BRCA2 Panel (Life Technologies))
Lab 13 Sequencing (NGS) Life Technologies IonPGM Short amplicon (BRCA MASTR Dx (Multiplicom))
Lab 14 Sequencing (NGS) Roche Diagnostics GS Junior Short amplicon (BRCA MASTR Dx (Multiplicom), Multiplicom BRCA HP (Multiplicom))
Lab 15 Sequencing (NGS) Roche Diagnostics GS Junior Short amplicon (BRCA MASTR Dx (Multiplicom))
Lab 16 HRM, dHPLC NA NA NA
Lab 17 HRM NA NA NA
  Sequencing (Sanger)      
Lab 18 Sequencing (Sanger) NA NA NA
Lab 19 Sequencing (Sanger) NA NA NA
Lab 20 Sequencing (Sanger) NA NA NA

Abbreviations: dHPLC=denaturing high performance liquid chromatography; HRM=high resolution melting; NA=not applicable; NGS=next-generation sequencing.